S&P 500: 662.29 -0.6% NASDAQ 100: 593.72 -0.6% Dow Jones: 466.41 -0.2%

Adaptive Biotechnologies Corporation

ADPT Healthcare
$13.17 +$0.72 (5.78%)
Market Cap: $2.03 B
Gurus Holding
7
Popularity Rank
#1121
% of Shares Held
21.93%
Net Activity (Q4 2025)
-$25.1 M

Guru Ownership Trend

Guru Analysis for Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Corporation (ADPT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $444.68 M.

Top institutional holders include Andreas Halvorsen and Catherine Wood.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $25.1 M net outflow during the quarter.

Recent activity highlights Ray Dalio who increased their stake by 75.5%. Conversely, Steven Cohen reduced exposure by 36.4%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$2.08 M
Total Buy Value
New Buys 0
Additions 2
-$27.18 M
Total Sell Value
Reductions 4
Sold Out 1

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
5
Net Buyers
2

FAQs for Adaptive Biotechnologies Corporation (ADPT)

Major holders include Andreas Halvorsen ($487.1 M), Catherine Wood ($34.74 M), Paul Tudor Jones ($9 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 33.76 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $25.1 M, with 2 managers increasing positions and 5 managers reducing holdings.

During the most recent reporting period, 4 managers trimmed their positions, while 1 fully exited ADPT. The total reported sell value was $27.18 M.

Yes, 0 managers opened new positions in ADPT, and 2 increased their existing holdings. The total reported buy value was $2.08 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
1.29% 29,993,708 $487.1 M Q4 2025
0.23% Reduce -32.4% 2,138,960 $34.74 M Q4 2025
0.02% Reduce -19.3% 554,037 $9 M Q4 2025
0.00% Reduce -23.1% 468,440 $7.61 M Q4 2025
0.02% Add 75.5% 265,491 $4.31 M Q4 2025
0.00% Reduce -36.4% 203,075 $3.3 M Q4 2025
0.01% Add 10.8% 140,756 $2.29 M Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form